Rating Change
Wells Fargo analysts initiated coverage on Progyny, Inc. (NASDAQ:PGNY) with a rating of Overweight on August 20, 2026.
new coverageNASDAQ:PGNY
Wells Fargo Initiates Coverage on Progyny, Inc. (PGNY) with Overweight
Wells Fargo analysts initiated coverage on Progyny, Inc. (NASDAQ:PGNY) with a rating of Overweight on August 20, 2026.
At publication ·
What changed
Progyny, Inc. (NASDAQ:PGNY) · new coverage
- Firm
- Wells Fargo
- Rating
- Overweight
- Price at event
- $25.96
- Market capitalization
- $2.2B
At a glance
Key takeaways
- Wells Fargo initiated coverage of Progyny (PGNY) with an Overweight rating on August 20, 2026, as the healthcare company trades at $25.96 with a $2.2 billion market capitalization.
Market Context
Progyny, Inc. operates in the Healthcare sector. The stock currently trades at $25.96 with a market capitalization of $2.2B.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Progyny, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Progyny, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | Wells Fargo | Overweight | N/A |
| Aug 13, 2026 | Truist Securities | Buy | N/A |
| Aug 12, 2026 | Barclays | Equal-Weight | N/A |
| Jul 28, 2026 | Barclays | Equal-Weight | N/A |
| Jul 24, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PGNY Stock Page
Frequently Asked Questions
What does the Overweight rating mean for PGNY?
A rating of Overweight from Wells Fargo reflects the analyst's outlook on Progyny, Inc. (NASDAQ:PGNY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PGNY forecast page.